BioSpace News Archive

Business

Shoreline Launches into “Era of Cell Therapy” with $4 Billion in Partnerships

Shoreline Biosciences was propelled into the proverbial catbird’s seat this summer with two mega-deals, and now plans to double its employee base from 50 to 100 in the coming months.

August 24, 2021
·
4 min read
·
Gail Dutton
Drug Development

Novartis’ Kymriah Disappoints in Phase III for Aggressive B-Cell NHL

Novartis reported that its Kymriah failed to hit its primary endpoint in the Phase III BELINDA trial in aggressive B-cell non-Hodgkin lymphoma after relapse or lack of response to first-line treatment.

August 24, 2021
·
2 min read
·
Mark Terry
Policy

Tonix Pharma Gets Go-Ahead from FDA for Long COVID Study

Shares of Tonix Pharmaceuticals were up nearly 11% in premarket trading after the company announced plans to initiate a Phase II study of TNX-102 SL as a potential treatment for Long COVID Syndrome following a positive meeting with the U.S. FDA.

August 24, 2021
·
2 min read
·
Alex Keown
Business

Money on the Move: August 18 – 24

The current continues as investment dollars flow into the life sciences. Here’s an overview who is catching the drift this week.

August 24, 2021
·
4 min read
·
Kate Goodwin
FDA

Pfizer-BioNTech COVID-19 Vaccine Receives Full Approval – Now What?

The new authorization is expected to be the final reassurance for many of those who had hesitated when the vaccine was approved under emergency use only.

August 24, 2021
·
3 min read
·
Heather McKenzie
Policy

U.S. Intelligence Report on COVID-19 Origins Expected Today

President Biden is expected to be briefed on the lab leak theory conducted over the last 90 days. Very few expect solid results, although this might provide direction for more lines of inquiry.

August 24, 2021
·
4 min read
·
Mark Terry
Business

Vertex and Arbor Strike a $1.2 Billion Deal for Gene-Editing Programs

With a handful of drugs for cystic fibrosis already approved, Vertex Pharmaceuticals has turned its attention to expanding its pipeline through collaborations and acquisitions the past few years.

August 24, 2021
·
2 min read
·
Kate Goodwin
Policy

CDC: Unvaccinated People are 29 Times More Likely to Be Hospitalized for COVID-19

The report also highlighted that an unvaccinated individual is five times more likely to get COVID-19 than someone who is fully vaccinated.

August 24, 2021
·
2 min read
·
Ellen Bombela
Business

Mega $3 Billion+ Deal Shapes Up for Roche to Target AD and Parkinson’s

Roche will apply RNAfix and Shape’s AAVid technology platform to develop next-generation tissue-specific adeno-associated viruses for new gene therapies aimed at these indications.

August 24, 2021
·
2 min read
·
Alex Keown
Deals

Working to Tackle Drug Resistance in Oncology Patients, Tyra Aims for $100 Million IPO

Tyra Biosciences aspires to raise a $100 million IPO, according to its S-1 form filed with the U.S. Securities and Exchange commission late last week.

August 24, 2021
·
2 min read
·
Ellen Bombela